FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Laszlo Bajzar

Research Profile

Chemicals & Drugs

Physiology

Concepts & Ideas

Living Beings

Infants

Co-author Network

Publications

TOP 3
Mary Bauman; K Black; M L Bauman; Stefan Kuhle; Laszlo Bajzar; M Patricia Massicotte
Warfarin induced coagulopathy in children: assessment of a conservative approach.
Mary Bauman; K Black; M L Bauman; A A K Bruce; Stefan Kuhle; Laszlo Bajzar; M Patricia Massicotte
EMPoWarMENT: Edmonton pediatric warfarin self-management pilot study in children with primarily cardiac disease.
Mary Bauman; K L Black; M L Bauman; Mark Belletrutti; Laszlo Bajzar; M Patricia Massicotte
Novel uses of insulin syringes to reduce dosing errors: a retrospective chart review of enoxaparin whole milligram dosing.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Laszlo Bajzar (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Mary Bauman; K Black; M L Bauman; Stefan Kuhle; Laszlo Bajzar; M Patricia Massicotte
Warfarin induced coagulopathy in children: assessment of a conservative approach.
Archives of disease in childhood 2011;96(2):164-7.
2010: Mary Bauman; K Black; M L Bauman; A A K Bruce; Stefan Kuhle; Laszlo Bajzar; M Patricia Massicotte
EMPoWarMENT: Edmonton pediatric warfarin self-management pilot study in children with primarily cardiac disease.
Thrombosis research 2010;126(2):e110-5.
2009: Mary Bauman; K L Black; M L Bauman; Mark Belletrutti; Laszlo Bajzar; M Patricia Massicotte
Novel uses of insulin syringes to reduce dosing errors: a retrospective chart review of enoxaparin whole milligram dosing.
Thrombosis research 2009;123(6):845-7.
2009: Mary E Bauman; Mark J Belletrutti; Laszlo Bajzar; Karina L Black; Stefan Kuhle; Michelle L Bauman; M Patricia Massicotte
Evaluation of enoxaparin dosing requirements in infants and children. Better dosing to achieve therapeutic levels.
Thrombosis and haemostasis 2009;101(1):86-92.
2008: Mary E Bauman; Karina L Black; M Patricia Massicotte; Michelle L Bauman; Stefan Kuhle; Susan Howlett-Clyne; George S Cembrowski; Laszlo Bajzar
Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin.
Thrombosis and haemostasis 2008;99(6):1097-103.
2008: John B Walker; Tanya M Binette; M Mackova; G R Lambkin; L Mitchell; Laszlo Bajzar
Proteolytic cleavage of carboxypeptidase N markedly increases its antifibrinolytic activity.
Journal of thrombosis and haemostasis : JTH 2008;6(5):848-55.
2007: Tanya M Binette; Fletcher B Taylor; Glenn Peer; Laszlo Bajzar
Thrombin-thrombomodulin connects coagulation and fibrinolysis: more than an in vitro phenomenon.
Blood 2007;110(9):3168-75.
2007: John B Walker; Laszlo Bajzar
Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors.
Journal of thrombosis and haemostasis : JTH 2007;5(6):1257-64.
2006: Stefan Kuhle; Alice Lau; Laszlo Bajzar; Patricia Vegh; Jacqueline Halton; Irene Cherrick; Ron Anderson; Brenda Osborne; Patricia McCusker; John Wu; Thomas C Abshire; Donald Mahoney; Lesley Mitchell
Comparison of the anticoagulant effect of a direct thrombin inhibitor and a low molecular weight heparin in an acquired antithrombin deficiency in children with acute lymphoblastic leukaemia treated with L-asparaginase: an in vitro study.
British journal of haematology 2006;134(5):526-31.
2006: Laszlo Bajzar; Anthony K C Chan; Mary Patricia Massicotte; Lesley G Mitchell
Thrombosis in children with malignancy.
Current opinion in pediatrics 2006;18(1):1-9.
2005: Michael E Nesheim; Laszlo Bajzar
The discovery of TAFI.
Journal of thrombosis and haemostasis : JTH 2005;3(10):2139-46.
2004: John B Walker; Laszlo Bajzar
The intrinsic threshold of the fibrinolytic system is modulated by basic carboxypeptidases, but the magnitude of the antifibrinolytic effect of activated thrombin-activable fibrinolysis inhibitor is masked by its instability.
The Journal of biological chemistry 2004;279(27):27896-904.
2004: Laszlo Bajzar; Nidhi Jain; Ping Wang; John B Walker
Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysis.
Critical care medicine 2004;32(5 Suppl):S320-4.
2004: Mark W C Hatton; Suzanne M R Southward; Kimberly J Legault; Bonnie L Ross; Bryan J Clarke; Laszlo Bajzar; Morris A Blajchman; Gurmit Singh; Mary Richardson
Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
The Journal of laboratory and clinical medicine 2004;143(4):241-54.
2003: Lindsay M Watson; Anthony K C Chan; Leslie R Berry; Jun Li; Sudesh K Sood; Jeffrey G Dickhout; Ling Xu; Geoff Werstuck; Laszlo Bajzar; Henry J Klamut; Richard C Austin
Overexpression of the 78-kDa glucose-regulated protein/immunoglobulin-binding protein (GRP78/BiP) inhibits tissue factor procoagulant activity.
The Journal of biological chemistry 2003;278(19):17438-47.
2003: John B Walker; Bernadette Hughes; Ian James; Peter Haddock; Cornelis Kluft; Laszlo Bajzar
Stabilization versus inhibition of TAFIa by competitive inhibitors in vitro.
The Journal of biological chemistry 2003;278(11):8913-21.
2001: D S Boskovic; Laszlo Bajzar; Michael E Nesheim
Channeling during prothrombin activation.
The Journal of biological chemistry 2001;276(31):28686-93.
2001: Michael E Nesheim; J Walker; W Wang; Michael B Boffa; Anton J G Horrevoets; Laszlo Bajzar
Modulation of fibrin cofactor activity in plasminogen activation.
Annals of the New York Academy of Sciences 2001;936():247-60.
2000: Laszlo Bajzar
Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(12):2511-8.
2000: RJ Stewart; James C Fredenburgh; Janice A Rischke; Laszlo Bajzar; Jeffrey I Weitz
Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator. A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator.
The Journal of biological chemistry 2000;275(47):36612-20.
1999: Petr Klement; Peng Liao; Laszlo Bajzar
A novel approach to arterial thrombolysis.
Blood 1999;94(8):2735-43.
1998: Lei Zhao; John Morser; Laszlo Bajzar; Michael E Nesheim; Mariko Nagashima
Identification and characterization of two thrombin-activatable fibrinolysis inhibitor isoforms.
Thrombosis and haemostasis 1998;80(6):949-55.
1998: W Wang; Michael B Boffa; Laszlo Bajzar; John B Walker; Michael E Nesheim
A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor.
The Journal of biological chemistry 1998;273(42):27176-81.
1998: Laszlo Bajzar; Michael E Nesheim; John Morser; Paula B Tracy
Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor.
The Journal of biological chemistry 1998;273(5):2792-8.
1998: Michael B Boffa; W Wang; Laszlo Bajzar; Michael E Nesheim
Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties.
The Journal of biological chemistry 1998;273(4):2127-35.
1997: Michael E Nesheim; W Wang; Michael B Boffa; Mariko Nagashima; John Morser; Laszlo Bajzar
Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis.
Thrombosis and haemostasis 1997;78(1):386-91.
1997: Peter A von dem Borne; Laszlo Bajzar; Joost C M Meijers; Michael E Nesheim; Bonno N Bouma
Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.
The Journal of clinical investigation 1997;99(10):2323-7.
1997: Hélène C F Côté; Laszlo Bajzar; WK Stevens; John Samis; John Morser; Ross T A MacGillivray; Michael E Nesheim
Functional characterization of recombinant human meizothrombin and Meizothrombin(desF1). Thrombomodulin-dependent activation of protein C and thrombin-activatable fibrinolysis inhibitor (TAFI), platelet aggregation, antithrombin-III inhibition.
The Journal of biological chemistry 1997;272(10):6194-200.
1996: Laszlo Bajzar; Michael Kalafatis; Paolo Simioni; Paula B Tracy
An antifibrinolytic mechanism describing the prothrombotic effect associated with factor VLeiden.
The Journal of biological chemistry 1996;271(38):22949-52.
1996: Laszlo Bajzar; Michael E Nesheim; Paula B Tracy
The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent.
Blood 1996;88(6):2093-100.
1996: Laszlo Bajzar; John Morser; Michael E Nesheim
TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex.
The Journal of biological chemistry 1996;271(28):16603-8.
1995: Laszlo Bajzar; R Manuel; Michael E Nesheim
Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor.
The Journal of biological chemistry 1995;270(24):14477-84.
1995: Waheed Sangrar; Laszlo Bajzar; Michael E Nesheim; Marlys L Koschinsky
Antifibrinolytic effect of recombinant apolipoprotein(a) in vitro is primarily due to attenuation of tPA-mediated Glu-plasminogen activation.
Biochemistry 1995;34(15):5151-7.
1994: Hélène C F Côté; W K Stevens; Laszlo Bajzar; D K Banfield; Michael E Nesheim; Ross T A MacGillivray
Characterization of a stable form of human meizothrombin derived from recombinant prothrombin (R155A, R271A, and R284A).
The Journal of biological chemistry 1994;269(15):11374-80.
1993: Laszlo Bajzar; Michael E Nesheim
The effect of activated protein C on fibrinolysis in cell-free plasma can be attributed specifically to attenuation of prothrombin activation.
The Journal of biological chemistry 1993;268(12):8608-16.